Liver transplantation by Groth, CG & Starzl, TE

002 
Bockus chap 116 Vol III b.b. 
only a compatible ABO blood group, the ab-
sence of malignancy or generalized sepsis 
and a reasonable similarity in size of the 
liver to that of the recipient. 
SURGICAL ~lkpfaboA TIONS 
Donor. Whole organ hepatic homografts 
can obviously be obtained from cadaveric 
donors only. Since 1968, when brain death 
criteria were accepted, it has been possible 
to harvest the grafts without a significant 
ischemic insult. The liver is cooled at removal 
and cleared of blood by brief perfusion 
with a chilled electrolyte solution. The re-
duction in temperature protects the organ 
from anoxic damage by markedly reducing 
the rate of metabolism. If removal of the 
graft cannot be delayed until the preparation 
of the recipient is complete, further storage 
can be accomplished by connecting the ca-
daver to a heart-lung machine or, even after 
removal of the liver, by artificial perfusion 
of the graft in a hyperbaric chamber under 
hypothermia. 
Orthotopic Transplantation.- r n orthotop-~-::::!:;;;;;;:;i:"D-";" 
ic liver transplantation, the native 1iver is 
removed and replaced by a graft with ana-
tomic reconstruction of the vasculature 
(Fig. 118-1). This entails end-to-end anas-
tomosis of the portal vein and of the inferior 
vena cava above and below the liver. When 
standard hepatic arterial anatom}l exists, 
reconstruction is by end-to-end anasto-
mosis. When there are anomalous arterial 
branches reaching the liver from the supe-
rior mesenteric artery or elsewhere, 2 anas-
tomoses or an anastomosis with a donor's 
aortic patch to the recipient's aorta may be 
required. 
Reconstruction of the biliary tract is most 
pommonly accomplished by anastomosis of 
the graft gallbladder to the recipient's duo-
tlenum after ligation of the common bile 
duct (Fig. 118-1). Alternative procedures 
include implantation of the graft commoh 
bile duct into the recipient's duodenum or 
jejunum, and end-to-end anastomosis of the 
graft and recipient's common bile ducts. 
j . The last procedure has the advantage of 
preserving a distal sphincter, but carries a 
higher risk of complications associated with 
bile leakage. It obviously cannot be applied 
in cases with biliary atresia. 
Heterotopic Transplantation. An alterna-
tive procedure in patients suffering from 
non-neoplastic liver disease is insertion of a 
hepatic graft leaving the native liver in place 
(Fig. 118-2). The possible advantages of re-
taining the residual function of the diseased 
native lever 'are oifset,llOwever, by s~veral 
factors: 1) portal hypertension remains 
unrelieved unless a shunt procedure is per-
formed; (2) the diseased liver may continue 
to be a threat to life as a potential site of 
hepatoma ;formation : (3) the abdominal 
overcrowding caused by the addition of an 
extra organ often leads to postoperative pul-
monary complications; and (4) residual 
function in a host liver may enable it, by a 
process loosely termed "interliver competi-
tion," to depreciate the chances of good 
function and survival of the transplant. 
Postoperative Care. Early in the history 
of liver transplantation, grafts damaged by 
ischemia were received by seve~al patients. 
The postoper'ltive course in these patients 
was complicated by hypoglycemia, severe 
clotting abnormalities and the development 
of a third fluid space with hypoproteinemia 
as well al severe electrolyte and acid-base 
disturbances. The early course after the 
provision of a minimally injured organ, by 
contrast, is usually not much different from 
what is seen after other kinds of major ab-
dominal surgery. Careful monitoring of arte-
rial blood gases, serum potassium and glu-
cose with swift and appropriate adjustments 
in therapy is important. Most patients bene-
fit from the intravenous administration of al-
bumin and diuretics over the first several 1 
postoperative days. Vitamin K is given to I 
support the synthesis of prothrombin. Anti-
biotics covering a broad spectrum of gram-
negative and gram-positive bacteria are 
usually administered during the' first post=-
operative week. , 1 . 
Technical Complications. Although por-
tal or caval vascular complications are un-
common, a 5 to 10 % frequency of hepatic 
arterial thrombosis has been reported. If the 
occlusion is complete, death usually ensues 
in a few hours. The complication is proba-
bly related to the small size of the vessels, 
especially in children, and the frequent oc-
currence of arterial vascular anomalies. 
Another possible contributory factor is al-
teration in blood coagulation influenced by 
the liver changes with the evolution of a 
hypercoagulable s'tate. _ 
Cholecystoduodenostomy seems ~pres­
ently to be the best, fi~tK ~!!oice for bilia!:y . I _ 
tract reconstruction , since it does not sacri- • 
fice any potentially useful biliary tract tis-
sue. Nevertheless, this kind of anastomosis • 
of the graft gallbladder to the recipient's 
duodenum has been accompanied by a 5 to ' 
10% frequency of obstruction at the site of 
the cystic duct. The obstruction results ei-
.: 
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ther from surgical error or from infection of 
the duct wall with agents such as cytomega-
lovirus (CMV). With obstruction, a rise in 
serum bilirubin and alkaline phosphatase, 
fever and gram-negative septicemia are 
characteristic findings. Secondary proce-
dures employing one of the other methods 
mentioned earlier have been performed, but 
so far all patients have died after reopera-
tion. Principally responsible for failme in 
such in tances is inability to control compli-
cating Intrahepatic abscesses or cholangitis. 
lthe~ unusual technical surgical compli-
cations include venous infarction of the 
right adrenal gla~d secondary to caval dis-
section, inadvertent crushing of the right 
phrenic nerve with vascular clamps placed 
on the suprahepatic inferior vena cava, and 
intraoperative air embolism. 
IMMUNOLOGIC CONSIDERA nONS 
Graft Rejection. Some animal re6pients 
of hepatic ho~ografts I particularly the pig 
and baboon , have' survived for prolonged 
periods without any immunosuppression. 
This had led t9,the conclusion that the liver 
enjoys an immunologic privilege in these 
sp,ecies. A similar situation may also exist in 
man. If so, however, it appears to offer so 
minor an advantage that it has yet to be 
conclusively demonstrated. Occurrence of 
episodes of rejection is the rule rather than 
the exception in humans. Moreover, there 
has been no apparent correlation between 
the severity of the immunologic attack and 
the degree of histocompatibility between 
donor and recipient. 
To date, there are no specific .tests for the 
diagnosis of rejection of a ep<ltic hom""o~---
graft. The most characteristic changes in the 
standard liver function tests include an in-
crease in serum bilirubin and alkaline phos-
phatase paralleling the concomitant morpho-
:'Iogic findings of intrahepatic cholestasis. If 
the rejection progresses, rises in the serum 
transaminases , prolongation of prothrombin 
time and other indications of cellular injury 
occur. The biochemical tests (Chapter 95) 
thus differentiate poorly between graft rejec-
tion and other forms of hepatic abnormality, 
such as biliary obstruction, infectious hepa-
titis and injury caused by drugs. Intra-
venous cholangiography (Chpater 121, Part 
I) , hepatic scans (Chapter 96, Part II), 
needle biopsy (Chapter 96, Part II) and de-
termination of HBAg in the serum all aid in 
differential diagnosis. 
Immunosuppression. The extensive ex-
perience with renal transplantation has i pro-
vided the foundation for the immunosup-
pressive regimens used in human hepatic 
transplantation. The first patients were 
given 2 immunosuppressive agents: the cy-
totoxic drug, azathioprine, and the synthetic 
adrenal corticosteroid , prednisone. During 
the last few years, horse antihuman lympho-
cyte globulin (ALG) has been added to this 
combination by some transplant teams. 
More recently, another cytotoxic agent, 
cyclosphosphamide, has been found to be as 
effective(aS! lmmunosuppressant as azatbio- f~ 
prine in man. Since it also may be less hepa-
totoxic, it has been used in the early post-
operative period to replace azathioprine in 
a triple drug program that has included 
ALG and sterofds. During the first post-
operative weeks, prednisone is given in very 
high doses; subsequently, the dose is gradu-
ally reduced. If evidence of graft rejection 
occurs, the steroid dose is again increased. 
With time, the amount of prednisone 
required tends to diminish. While the mech-
anism underlying this "graft acceplance" is 
poorly understood, it is prerequisite for 
long-term success because the side-effects 
of prolonged administration of high doses of 
prednisone are prohibitive. 
Inadequate control of homograft rejection 
has been a major cause of failure in approxi-
mately one third of the patients treated to 
this time. A second transplantation has been 
carried out in a few patients when graft in-
sufficiency resulting from rejection became 
severe. In one case, the recipient of a sec-
ond graft survived for more than a year. 
The Compromised Host. The dilemma of 
chronic immunosuppression is to provide 
enough therapy to prevent rejection, yet not 
so much that the patient dies of immuno-
logic invalidism. This fine balance may not 
be achievable in a given case. The post- ~ 
operative course in a large number of patients 
is complicated by severe pulmonary dr sys-
temic infections. Often, the infectious agent 
. is an opportunistic organism that becomes 
pathogenic only in an immunologically com-
promised host. Examples of such agents are 
candida, aspergillus, nocardia and crypto-
coccus among the fungi; cytomegalovirus, 
herpes simplex and varicella-zoster among ' 
the viruses; and a nonclassified microorga-
ni~mI Pneumocystis carinii. Infections with 
all these organisms have been encountered 
in recipients of hepatic transplants. In many 
patients these infections have contributed to 
eady or late postoperative death. 
Recipients of liver transplants also have a 
high incidence of septicemia caused by 
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gram-negative b<fteria of the types constitu-
ting the endogenous bowel flora . Evidence 
indicates that the hepatic graft, during -bil-
iary obstruction or when afflicted by rejec-
tion , readily becomes infected with intesti-
nal bacteria. The latter then enter the 
systemic circulation. Large septic infarcts 
develop in some patients , probably as a 
consequence of uncontrolled rejection. 
Frequent blood cultures are mandatory in 
caring for these recipients. Demonstration 
of gram-negative bacteria in the blood 
stream is strong evidence of graft obstruc-
tion , rejection or serious injury from other 
causes , including hepatic vascular throm-
bosis. 
Another possibility is that the rapidity 
aQd extent of occurrence of post-transplan-
tation metastases in patients treated for he-
patic malignancy is related to the immu-
nosuppressive treatment. Loss of the 
" immunologic surveillance" by which mu-
tant cells can be eliminated or restricted in 
their potential growth has been postulated 
as instrumental in the immunologically com-
promised patients. 
RESULTS 
Of the still limited number of recipients of 
orthotopic grafts (some 123 as of Jaunuary, 
1972), only a little more than 10% surviyed 
past the first postoperative year. Three pa-
, tients survived for more than 3 years and 2 
of them are reported to have remained in 
excellent health. Death early after hepatic 
transplantation has been found to result 
from many causes: hemorrhage, vascular 
thrombosis, focal septic necrosis in the 
graft, biliary fistula or obstruction and rejec-
tion. When death ensued several months 
after the operation, it was usually due to 
chronic rejection; carcinomatosis or serum 
hepatitis. Fatal sepsis occurred both early 
and late in the postoperative course. A 
small group of patients died from nonseptic 
disease afflicting organs other than the liver. 
The resultS obtainea at the University of ' 
Colorado, the in ~titution in the United 
States with the gdatest experience to date 
with liver transplantation , are considerably 
better than those reflected in the total series. 
Of 56 patients who had an orthotopic liver 
transplantation at the University of Col-
orado 4 or more months earlier, 19 lived (or 
at least the first 4 months and ] 1 survived 
for at least 1 year. The patient with the 
longest survival (3 1/2 years) had biliary atre-
sia. 
Encouraging results have also been 
achieved at the University of Colorado in 
the treatment of hepatolenticular degenera-
tion (Chapter 112). Two teenage boys suf-
fering from this disease are alive and well as 
of this writing for more than 1 and 3 years, 
respectively, after orthotopic transplanta-
tion. Biopsy specimens have shown no ac-
cumulation of copper in the grafts; in the 
second patient, markedly suppressed serum 
copper and ceruloplasmin have normalized. 
This experience is consistent with the hy-
pothesis that the metabolic defect in Wil-
son's disease is liver based, although it does 
not prove it (Chapter 112). 
The worst results after transplantation for 
benign liver disease in the CoLorado series 
have been in patients suffering from Laen-
nec 's cirrhosis or primary biliary cirrhosis. 
None of these patients survived postopera-
tively beyond 1 year: These poor results are 
probably due to the unfavorable selection of :",,-"f :"Dg~ 
cases mentioned earlier and should 0 ais-+ /~ } _~ ___ --4,... 
courage further efforts to operate upon such 4i 
patients. 
Of 16 patients with malignant hepatic 
I 
turpor who have thus far been reported to 
have undergone liver transplantation and 
who lived more than 3 months afterward, 11 
eventually died of tumor recurrence. Two 
patients died of other causes and 3 are alive 
with no malignancy after more than 2 years. 
I I. The malignancy was an incidental finding in 
2 of the 16 patients, the primary diagnosis 
being biliary atresia in one and Laennec's 
cirrhosis in the other. 
There has ' not been an instance of ex-
tended survival among the 35 patients 
treated throughout the world with heterotop-
ic hepatic transplantation as of Jaunary , 
1972. Most of the recip.ients died in the first 
postoperative months from complications 
directly related to the grafting, or from pro-
gressive hepatic insufficiency not relieved 
by 'the transplantation. Other patients died 
fro septic conditions or circulatory or res-
pir tory failure. In a few cases7'the ~onfunc-
tioiling transplant was removed at a second -
operation. The inherent disadvantages of . 
the method tdiscussed previously probably 
account for the poor results. 
Because of the high proportion of patients 
with biliary atresia, about 45% of ~fl liver 
transplant recipients have been younger than 
5 years of age. No other organ bas been 
transplanted so frequently in small children. 
FUTURE PROSPECTS 
," 
'i 
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Although the difficulties encolintered in 
the field of hepatic transplantation have 
been numerous, there is every reason to feel 
that the prospects for success should soon 
become as good as for cadaveric renal trans-
plantation. Several avenues for improve-
ment are obvious. First, the operation 
should be performed at an earlier stage, i.e., 
before the patient's general condition is as 
agonal as has so often been the case in the 
past. The responsibility for this important 
change lies mainly with the referring physi-
cian. Second, extensive collaboration within 
the medical community regarding utilization 
of organs from patients with brain death 
would increase the chances of treating more 
patients at the right time. Third , careful 
preoperative evaluation of vascular and bil-
iary anatomy, primarily with radiographic 
techniques, might prevent some of the tech-
nical complications. Fourth, patients with 
hepatic malignancy should probably be ex-
cluded from consideration, at least for the 
time being. Finally, further improvements in 
the means for controlling the immune re-
sponse are crucial. 
With improved results, the indications for 
hepatic transplantation can be ex anded. In 
addition to the""i1u'"mberous .... atlents suffenng 
from severe destructive nepatic disease, the 
procedure would benefit a large number of 
patients with liver-based errors of metabo-
lism. 
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